The recent suggestion that the administration of aspirin might be useful in the treatment of sickle-cell anemia has been further studied and found to be without basis. After incubation with aspirin, sickle-_cell erythrocytes are not inhibited from sickling after deoxygenation. In addition, although aspirin does transfer the acetyl group to hemoglobin both in vitro and in vivo, in our experiments the reaction does not result in any alteration in the oxygen equilibrium of either intact erythrocytes or hemoglobin in solution. Furthermore, patients maintained on long-term aspirin administration also showed no shift in the oxygen affinity of their blood.
Recently Klotz and Tam (1) have suggested that aspirin (acetylsalicylic acid, ASA) might be an alternative drug to sodium cyanate (2, 3) for the treatment of sickle-cell anemia. The rationale for their proposal arose from the well recognized transfer in vitro and in vivo of the acetyl group of acetylsalicylic acid to the c-NH2 group of lysine of serum albumin (4, 5) . To support their hypothesis Klotz and Tam (1) reported that erythrocytes incubated in vitro with [14C]acetylsalicylic acid incorporated [14Cjacetyl groups into acid-precipitable protein.
They also observed a substantial increase in the oxygen affinity of both erythrocytes and hemolysates after incubation with ASA. The possibility was considered that this shift in the oxygen dissociation curve was a result of acetylation of the NH2terminal valines, since a similar shift is observed following carbamylation of these functional groups by cyanate (6) (7) (8) .
Since it is the modification of this group that is believed to be the basis for the use of cyanate in sickle-cell anemia (2) , the potential use of ASA presented an exciting new possibility. To further evaluate this hypothesis we have examined the effect of ASA on the oxygen affinity of (1) the blood of patients treated with ASA for prolonged periods, (2) the blood of rats administered ASA orally and intraperitoneally, (3) (10) .
Three groups of six female Holtzman rats (300 g) received daily (five times/week) either (a) 100 mg/kg of ASA injected intraperitoneally, (b) 100 mg/kg administered orally by intubation, or (c) 100 mg/kg of NaCl injected intraperitoneally. The ASA was dissolved fresh daily in 5% NaHCO3 and adjusted to a final pH and concentration of 7.4 and 20 mg/ml, respectively. The blood was obtained by cardiac puncture from different animals at the designated intervals.
Holtzman rats (300 g) were injected intraperitonally with 100 mg/kg of ["4C]acetylsalicylic acid (specific activity 4 X 105 dpm/gmol). After 24 hr a 2-ml sample of blood was obtained and centrifuged. The plasma was drawn off and the proteins precipitated with cold 5% trichloroacetic acid solution and the precipitate was washed three times with 5% trichloroacetic acid. Prior to acid precipitation the cells were washed three times with saline to remove plasma proteins. The acid-precipitated proteins were oxidized and the 14C radioactivity determined.
For the study of erythrocytes in vitro, the blood was centrifuged at 1200 X g and the plasma put aside. The erythrocytes were then washed three times with phosphatebuffered saline (PBS), pH 7.4 (11) . A 20 mM ASA solution was prepared by dissolving the ASA in PBS, pH 7.4, and adjusting the pH to 7.4 with isotonic NaHCO3. In the experiments utilizing radioactive ASA, one part of [14C]acetylsalicylic acid was diluted with nine parts of nonradioactive ASA. Packed erythrocytes were suspended either in an equal volume of PBS, pH 7.4, or an equal volume of 20 mM ASA solution (final concentration 10mM ASA). In addition, glucose was added to the incubation mixture to a final concentration of 1 mg/ml. The cells were then incubated at 370 in a shaking waterbath for the designated time intervals. At the end of the incubation the erythrocytes were washed three times with PBS, pH 7.4, and finally were resuspended in their original plasma. The oxygen affinity and DPG concentrations were determined as outlined above. The oxygen affinity of the hemoglobin of control and ASAtreated erythrocytes was measured as previously described (12) . After the washed cells had been lysed and the stroma removed by centrifugation, the hemoglobin solutions were passed through a Sephadex G-25 column equilibrated with 0.1 M NaCl, 0.01 M Tris * HCl (pH 7.0). This step removed the unreacted ASA. The DPG was removed by dialyzing the hemoglobin solution in a stretched membrane (13) for 18 hr against 0.1 M NaCl. The spectra at different percent oxygen saturations of the hemoglobin solution [0.1 mM tetramer in 0.1 M NaCl, 0.05 M bis-(2-hydroxyethyl)imino-tris-(hy- The filter was then oxidized in a Packard Oxidizer and the amount of radioactivity determined in a Packard Liquid Scintillation Counter. The deoxygenation of the treated and untreated erythrocytes (S/S) was carried out in an IL 237 tonometer at 370 (9).
After the blood was equilibrated with a gas mixture containing 20% 02 and 5.64% CO2 (balance nitrogen) the percent saturation of the hemoglobin was measured. An aliquot of cells equilibrated as above was fixed in buffered formalin. The equilibrating gas mixture was then switched to one containing only CO2 (5.64%) and nitrogen. Aliquots of blood were removed at 3-min intervals both for determination of the percent oxygen saturation and for fixation. The fixed cells were smeared and stained with Wright's stain on coded glass slides.
The percentage of severely sickled cells present in 2000 cells was then determined by an independent observer. (14) . Subsequent to our inability to observe an increase of the oxygen affinity of blood of patients and animals receiving ASA, we reinvestigated the reported effect of ASA on erythrocytes in vitro. In contrast to the impressive change in oxygen affinity after incubation of erythrocytes in vitro with ASA reported by Klotz and Tam, we observed no significant effect (Table 3 ). The oxygen affinity and DPG content of fresh normal erythrocytes (A/A), DPG-depleted erythrocytes (A/A), and sickle-cell erythrocytes (S/S) were not different from those of cells incubated similarly with ASA. In addition, the oxygen affinity of the hemoglobin from cells incubated for extended periods of time with ASA was not altered, although appreciable amounts of acetylation of the hemoglobin had occurred. The amounts were comparable to those reported by Klotz and Tam (1) . The addition of DPG to the ASAtreated hemoglobin resulted in the expected decrease in the oxygen affinity. The hemoglobin containing the 14C radioactivity had an isoelectric focusing point less than HbA, in the (Table 4) .
RESULTS

DISCUSSION
The proposed use of aspirin in the treatment of sickle-cell anemia was based on the presumed similarity in specificity of the acetylation by ASA with the specific carbamylation by cyanate of the NH2-terminal valine of hemoglobin. The carbamylation of the NH2-terminal valine of the a chain of hemoglobin leads to a significant increase in the oxygen affinity of the hemoglobin (6). This shift is believed to be the result of the masking of the amino group that is involved in a salt bridge that stabilizes the deoxy conformation (15) . The reported increase in the oxygen affinity or erythrocytes after incubation with ASA was taken as evidence that the acetylation had also primarily masked this functional group (1). We have not been able to confirm this effect. Our experiments show that, although acetylation of the hemoglobin occurred to the same extent as previously reported (1) , no change in the oxygen affinity was observed. It is not clear to us why Klotz and Tam observed an increase in the oxygen affinity of erythrocytes after incubation with ASA. Perhaps, the cells that were incubated with ASA became partially depleted of DPG, resulting in increased oxygen affinity.
We interpret the retention of a normal oxygen affinity as evidence that the acetylation reaction occurred at a site other than the NH2-terminal valine of the a chain (6) . One of the interesting questions remaining is whether the acetylation is occurring at a specific location on the hemoglobin molecule. Since aspirin has been shown to acetylate a specific lysine residue of albumin in the region of the binding site for salicylates, it might be that a similar salicylate-binding site is present on 'hemoglobin, which facilitates the transfer of the acetyl group. Such a specificity might have clinical application if it could be exploited to alter the functional abnormalities of a hemoglobin variant that has an amino-acid substitution in this region.
